GlassScriptPhysician profile
Douglas Bailyn
NPI 1306885470
$6,792.86
in general payments reported to CMS, 2019-2025
37 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what 83% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $63.83 · 2021: $637 · 2022: $986 · 2023: $1,556 · 2024: $1,564 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,389 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,389.06 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,345.68 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Gilead Sciences, INC. | $894.63 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $762.38 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Viiv Healthcare Company | $689.50 | 2022-2025 | Apretude |
| Lilly USA, LLC | $645.31 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $225.26 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Corium, LLC | $216.90 | 2022-2025 | Azstarys |
| Pfizer INC. | $166.89 | 2019-2024 | |
| Axsome Therapeutics, INC. | $154.34 | 2024-2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $153.25 | 2019-2025 | Trintellix |
| Exact Sciences Corporation | $144.01 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $141.11 | 2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $134.31 | 2019-2025 | Krystexxa, Tavneos |
| Almatica Pharma LLC | $123.29 | 2023-2025 | Loreev Xr, Gralise, Sertraline Hcl |
| Merck Sharp & Dohme LLC | $115.63 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $82.22 | 2022-2023 | Acthar |
| Otsuka America Pharmaceutical, INC. | $74.45 | 2019-2023 | Jynarque |
| Bausch Health US, LLC | $65.13 | 2024-2025 | Aplenzin, Wellbutrin |
| Abbott Laboratories | $63.43 | 2022-2023 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $59.32 | 2022-2023 | Aptima |
| Astellas Pharma US INC | $53.48 | 2024-2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $51.41 | 2022-2023 | Quviviq |
| Allergan, INC. | $50.23 | 2019-2020 | |
| Kaleo, INC. | $49.82 | 2022 | |
| Dexcom, INC. | $46.84 | 2024 | Dexcom G6 Transmitter |
| Phadia US INC. | $36.59 | 2019-2025 | Immunocap |
| Ironshore Pharmaceuticals INC. | $35.48 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.58 | 2025 | Zoryve |
| Itamar Medical INC | $26.70 | 2025 | Watchpatone |
| Phathom Pharmaceuticals, INC. | $26.24 | 2025 | Voquezna |
| Amag Pharmaceuticals, INC. | $25.00 | 2019 | |
| Genentech USA, INC. | $20.06 | 2021 | |
| Horizon Therapeutics Plc | $20.03 | 2022 | |
| Antares Pharma, INC. | $18.69 | 2023 | Nocdurna, Tlando, Xyosted |
| Sanofi Pasteur INC. | $18.40 | 2023 | |
| Arbor Pharmaceuticals, INC. | $14.67 | 2019 | |
| Optinose US, INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Bailyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.